After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Award
Reported value range
Not reported

Gabay Avraham Chief Financial Officer

Transaction date Nov 12, 2026
Public filing date Nov 13, 2026
Filing lag Filed 1 day later

ORMP daily price context

Close on/before transaction
$4.03 Nov 12, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
242,000 shares
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0001213900-26-120033
Filing cohort

Transactions in this filing

Showing 2 of 2
Trades
2
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Oramed Pharmaceuticals Inc. ORMP Current Award Nov 12, 2026 Not reported
Oramed Pharmaceuticals Inc. ORMP Award Nov 12, 2026 Not reported